Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritis

Ann Rheum Dis. 2009 May;68(5):759-61. doi: 10.1136/ard.2008.095505.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Amyloidosis / drug therapy*
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis / complications*
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Male
  • Serum Amyloid A Protein
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Serum Amyloid A Protein
  • Tumor Necrosis Factor-alpha
  • Infliximab